These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38131633)

  • 41. Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III.
    Reja M; Makar M; Visaria A; Marino D; Rustgi V
    Ann Hepatol; 2020; 19(6):635-640. PubMed ID: 32745632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
    Li L; Huang Q; Yang L; Zhang R; Gao L; Han X; Ji L; Zou X
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.
    Yang N; Lu Y; Cao L; Lu M
    J Clin Lab Anal; 2022 Feb; 36(2):e24225. PubMed ID: 34997649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of Serum Uric Acid Level With Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Liver Fibrosis in Korean Men and Women: A Cross-Sectional Study Using Nationally Representative Data.
    Lee JM; Kim HW; Heo SY; Do KY; Lee JD; Han SK; Baik SK; Kim MY; Chang SJ
    J Korean Med Sci; 2023 Aug; 38(34):e267. PubMed ID: 37644682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018.
    Heredia NI; Zhang X; Balakrishnan M; Daniel CR; Hwang JP; McNeill LH; Thrift AP
    Prev Med; 2022 Jan; 154():106903. PubMed ID: 34861339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.
    Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS
    Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between serum selenium and non-alcoholic fatty liver disease: Results from NHANES: An observational study.
    Liu Y; Wang R
    Medicine (Baltimore); 2024 Jul; 103(28):e38845. PubMed ID: 38996172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017-18.
    Spaur M; Nigra AE; Sanchez TR; Navas-Acien A; Lazo M; Wu HC
    Environ Res; 2022 Oct; 213():113647. PubMed ID: 35691383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.
    Kim MJ; Lee KJ
    BMC Pediatr; 2020 Mar; 20(1):121. PubMed ID: 32171275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease.
    Younossi ZM; Felix S; Jeffers T; Younossi E; Nader F; Pham H; Afendy A; Cable R; Racila A; Younoszai Z; Lam BP; Golabi P; Henry L; Stepanova M
    JAMA Netw Open; 2021 Sep; 4(9):e2123923. PubMed ID: 34529067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
    Ciardullo S; Perseghin G
    Metabolism; 2021 Aug; 121():154752. PubMed ID: 33716004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.
    Kim D; Kim W; Adejumo AC; Cholankeril G; Tighe SP; Wong RJ; Gonzalez SA; Harrison SA; Younossi ZM; Ahmed A
    Hepatol Int; 2019 Mar; 13(2):205-213. PubMed ID: 30694445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018.
    Ji Y; Wei CB; Gu W; Hou LL
    Ann Med; 2023 Dec; 55(1):2209335. PubMed ID: 37155562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017-2018.
    Cheng W; Li M; Zhang L; Zhou C; Zhang X; Zhu C; Tan L; Lin H; Zhang W; Zhang W
    Ann Med; 2023 Dec; 55(1):2216943. PubMed ID: 37323015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017-2018.
    Tan L; Zhou Q; Liu J; Liu Z; Shi R
    Food Funct; 2023 Jun; 14(12):5653-5662. PubMed ID: 37249386
    [No Abstract]   [Full Text] [Related]  

  • 60. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
    Ciardullo S; Muraca E; Zerbini F; Manzoni G; Perseghin G
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2856-e2865. PubMed ID: 33878156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.